vs

Side-by-side financial comparison of BRC Inc. (BRCC) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

BRC Inc. is the larger business by last-quarter revenue ($112.7M vs $75.5M, roughly 1.5× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 6.5%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-9.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 7.0%).

BRC Inc., operating under the Black Rifle Coffee brand, is a U.S.-headquartered premium coffee and lifestyle brand. It sells roasted coffee beans, ready-to-drink coffee products, branded apparel, and outdoor gear, targeting primarily veteran, first responder, and outdoor enthusiast consumer segments across North America, via both e-commerce and physical retail channels.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

BRCC vs PBYI — Head-to-Head

Bigger by revenue
BRCC
BRCC
1.5× larger
BRCC
$112.7M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+21.2% gap
PBYI
27.7%
6.5%
BRCC
More free cash flow
PBYI
PBYI
$23.8M more FCF
PBYI
$14.4M
$-9.4M
BRCC
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
7.0%
BRCC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BRCC
BRCC
PBYI
PBYI
Revenue
$112.7M
$75.5M
Net Profit
$-3.2M
Gross Margin
32.1%
69.3%
Operating Margin
-6.3%
22.7%
Net Margin
-2.8%
Revenue YoY
6.5%
27.7%
Net Profit YoY
-29.3%
EPS (diluted)
$-0.02
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRCC
BRCC
PBYI
PBYI
Q4 25
$112.7M
$75.5M
Q3 25
$100.7M
$54.5M
Q2 25
$94.8M
$52.4M
Q1 25
$90.0M
$46.0M
Q4 24
$105.9M
$59.1M
Q3 24
$98.2M
$80.5M
Q2 24
$89.0M
$47.1M
Q1 24
$98.4M
$43.8M
Net Profit
BRCC
BRCC
PBYI
PBYI
Q4 25
$-3.2M
Q3 25
$-486.0K
$8.8M
Q2 25
$-5.3M
$5.9M
Q1 25
$-2.9M
$3.0M
Q4 24
$-2.5M
Q3 24
$-535.0K
$20.3M
Q2 24
$-482.0K
$-4.5M
Q1 24
$548.0K
$-4.8M
Gross Margin
BRCC
BRCC
PBYI
PBYI
Q4 25
32.1%
69.3%
Q3 25
36.9%
77.7%
Q2 25
33.9%
76.5%
Q1 25
36.1%
77.1%
Q4 24
38.1%
76.4%
Q3 24
42.1%
63.9%
Q2 24
41.9%
77.4%
Q1 24
42.9%
75.5%
Operating Margin
BRCC
BRCC
PBYI
PBYI
Q4 25
-6.3%
22.7%
Q3 25
0.5%
17.6%
Q2 25
-13.3%
12.7%
Q1 25
-6.0%
8.7%
Q4 24
-2.1%
22.6%
Q3 24
1.1%
27.4%
Q2 24
1.1%
-4.6%
Q1 24
4.0%
-5.3%
Net Margin
BRCC
BRCC
PBYI
PBYI
Q4 25
-2.8%
Q3 25
-0.5%
16.2%
Q2 25
-5.6%
11.2%
Q1 25
-3.2%
6.5%
Q4 24
-2.3%
Q3 24
-0.5%
25.2%
Q2 24
-0.5%
-9.6%
Q1 24
0.6%
-11.0%
EPS (diluted)
BRCC
BRCC
PBYI
PBYI
Q4 25
$-0.02
$0.26
Q3 25
$0.00
$0.17
Q2 25
$-0.07
$0.12
Q1 25
$-0.04
$0.06
Q4 24
$-0.03
$0.40
Q3 24
$-0.01
$0.41
Q2 24
$-0.01
$-0.09
Q1 24
$0.01
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRCC
BRCC
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$4.3M
$97.5M
Total DebtLower is stronger
$34.7M
$22.7M
Stockholders' EquityBook value
$45.7M
$130.3M
Total Assets
$209.2M
$216.3M
Debt / EquityLower = less leverage
0.76×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRCC
BRCC
PBYI
PBYI
Q4 25
$4.3M
$97.5M
Q3 25
$9.5M
$94.4M
Q2 25
$4.3M
$96.0M
Q1 25
$3.9M
$93.2M
Q4 24
$6.8M
$101.0M
Q3 24
$7.3M
$96.7M
Q2 24
$9.6M
$96.8M
Q1 24
$4.0M
$107.2M
Total Debt
BRCC
BRCC
PBYI
PBYI
Q4 25
$34.7M
$22.7M
Q3 25
$35.0M
$34.0M
Q2 25
$72.7M
$45.3M
Q1 25
$68.8M
$56.7M
Q4 24
$65.1M
$68.0M
Q3 24
$64.9M
$79.3M
Q2 24
$66.5M
$90.7M
Q1 24
$61.5M
$102.0M
Stockholders' Equity
BRCC
BRCC
PBYI
PBYI
Q4 25
$45.7M
$130.3M
Q3 25
$48.0M
$115.3M
Q2 25
$10.1M
$104.7M
Q1 25
$11.2M
$97.1M
Q4 24
$13.2M
$92.1M
Q3 24
$14.5M
$71.1M
Q2 24
$14.9M
$48.5M
Q1 24
$14.6M
$51.0M
Total Assets
BRCC
BRCC
PBYI
PBYI
Q4 25
$209.2M
$216.3M
Q3 25
$222.4M
$202.9M
Q2 25
$225.3M
$194.9M
Q1 25
$222.9M
$196.2M
Q4 24
$227.4M
$213.3M
Q3 24
$233.7M
$220.7M
Q2 24
$229.9M
$205.0M
Q1 24
$227.2M
$214.1M
Debt / Equity
BRCC
BRCC
PBYI
PBYI
Q4 25
0.76×
0.17×
Q3 25
0.73×
0.30×
Q2 25
7.19×
0.43×
Q1 25
6.15×
0.58×
Q4 24
4.94×
0.74×
Q3 24
4.47×
1.12×
Q2 24
4.46×
1.87×
Q1 24
4.21×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRCC
BRCC
PBYI
PBYI
Operating Cash FlowLast quarter
$-8.7M
$14.4M
Free Cash FlowOCF − Capex
$-9.4M
$14.4M
FCF MarginFCF / Revenue
-8.3%
19.1%
Capex IntensityCapex / Revenue
0.6%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.5M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRCC
BRCC
PBYI
PBYI
Q4 25
$-8.7M
$14.4M
Q3 25
$6.4M
$9.7M
Q2 25
$-3.3M
$14.1M
Q1 25
$-4.1M
$3.6M
Q4 24
$2.2M
$15.6M
Q3 24
$1.9M
$11.0M
Q2 24
$2.3M
$1.0M
Q1 24
$4.9M
$11.2M
Free Cash Flow
BRCC
BRCC
PBYI
PBYI
Q4 25
$-9.4M
$14.4M
Q3 25
$5.6M
$9.7M
Q2 25
$-4.3M
$14.1M
Q1 25
$-5.3M
$3.6M
Q4 24
$504.0K
$15.6M
Q3 24
$-205.0K
$11.0M
Q2 24
$147.0K
$1.0M
Q1 24
$2.2M
FCF Margin
BRCC
BRCC
PBYI
PBYI
Q4 25
-8.3%
19.1%
Q3 25
5.5%
17.7%
Q2 25
-4.5%
26.8%
Q1 25
-5.9%
7.7%
Q4 24
0.5%
26.4%
Q3 24
-0.2%
13.7%
Q2 24
0.2%
2.1%
Q1 24
2.2%
Capex Intensity
BRCC
BRCC
PBYI
PBYI
Q4 25
0.6%
0.0%
Q3 25
0.8%
0.0%
Q2 25
1.0%
0.0%
Q1 25
1.3%
0.1%
Q4 24
1.6%
0.0%
Q3 24
2.2%
0.0%
Q2 24
2.4%
0.0%
Q1 24
2.8%
0.0%
Cash Conversion
BRCC
BRCC
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24
8.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BRCC
BRCC

Sales Channel Through Intermediary$72.9M65%
Sales Channel Directly To Consumer$34.4M31%
Outpost$5.4M5%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons